FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lance Thomas

Research Profile

Chemicals & Drugs

Phenomena

Protein Binding

Anatomy

Co-author Network

Publications

TOP 3
Lianghua Bin; Jacqueline Thorburn; Lance R Thomas; Peter E Clark; Robin Humphreys; Andrew Thorburn
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding.
Lance R Thomas; Laura M Bender; Michael J Morgan; Andrew Thorburn
Extensive regions of the FADD death domain are required for binding to the TRAIL receptor DR5.
Joseph T O'Flaherty; LeAnn C Rogers; Christian Paumi; Roy R Hantgan; Lance R Thomas; Carl Clay; Kevin High; Yong Q Chen; Mark C Willingham; Pamela K Smitherman; Timothy E Kute; Anuradha Rao; Scott D Cramer; Charles S Morrow
5-Oxo-ETE analogs and the proliferation of cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lance Thomas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Lianghua Bin; Jacqueline Thorburn; Lance R Thomas; Peter E Clark; Robin Humphreys; Andrew Thorburn
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding.
The Journal of biological chemistry 2007;282(38):28189-94.
2006: Lance R Thomas; Laura M Bender; Michael J Morgan; Andrew Thorburn
Extensive regions of the FADD death domain are required for binding to the TRAIL receptor DR5.
Cell death and differentiation 2006;13(1):160-2.
2005: Joseph T O'Flaherty; LeAnn C Rogers; Christian Paumi; Roy R Hantgan; Lance R Thomas; Carl Clay; Kevin High; Yong Q Chen; Mark C Willingham; Pamela K Smitherman; Timothy E Kute; Anuradha Rao; Scott D Cramer; Charles S Morrow
5-Oxo-ETE analogs and the proliferation of cancer cells.
Biochimica et biophysica acta 2005;1736(3):228-36.
2005: Laura M Bender; Michael J Morgan; Lance R Thomas; Z-G Liu; Andrew Thorburn
The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm.
Cell death and differentiation 2005;12(5):473-81.
2005: Jacqueline Thorburn; Franklin Moore; Anuradha Rao; Wendy W Barclay; Lance R Thomas; Ken W Grant; Scott D Cramer; Andrew Thorburn
Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells.
Molecular biology of the cell 2005;16(3):1189-99.
2004: Lance R Thomas; Ronald L Johnson; John C Reed; Andrew Thorburn
The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
The Journal of biological chemistry 2004;279(50):52479-86.
2004: Lance R Thomas; Adrianna Henson; John C Reed; Freddie Salsbury; Andrew Thorburn
Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
The Journal of biological chemistry 2004;279(31):32780-5.
2004: Peter Eriksson; Lance R Thomas; Andrew Thorburn; David J Stillman
pRS yeast vectors with a LYS2 marker.
BioTechniques 2004;36(2):212-3.
2002: Leena T Bhoite; Jason M Allen; Emily Garcia; Lance R Thomas; I David Gregory; Warren P Voth; Kristen Whelihan; Ronda J Rolfes; David J Stillman
Mutations in the pho2 (bas2) transcription factor that differentially affect activation with its partner proteins bas1, pho4, and swi5.
The Journal of biological chemistry 2002;277(40):37612-8.
2002: Lance R Thomas; David J Stillman; Andrew Thorburn
Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen.
The Journal of biological chemistry 2002;277(37):34343-8.